4,168 research outputs found
A New Iron Pnictide Oxide (Fe2As2)(Ca5(Mg,Ti)4Oy) and a New Phase in Fe-As-Ca-Mg-Ti-O system
A new layered iron arsenide oxide (Fe2As2)(Ca5(Mg,Ti)4Oy) and its structural
derivative were found in the Fe-As-Ca-Mg-Ti-O system. The crystal structure of
(Fe2As2)(Ca5(Mg,Ti)4Oy) is identical to that of (Fe2As2)(Ca5(Sc,Ti)4Oy), which
was reported in our previous study. The lattice constants of this compound are
a = 3.86(4) A and c = 41.05(2) A. In addition, another phase with a thicker
blocking layer was found. The structure of the compound and its derivative was
tentatively assigned through STEM observation as (Fe2As2)(Ca8(Mg,Ti)6Oy) with
sextuple perovskite-type sheets divided by a rock salt layer. The interlayer
Fe-Fe distance of this compound is ~30 A. The compound and its derivative
exhibited bulk superconductivity, as found from magnetization and resistivity
measurements.Comment: 9 pages, 7 figure
Evidence for Nodal superconductivity in SrScFePO
Point contact Andreev reflection spectra have been taken as a function of
temperature and magnetic field on the polycrystalline form of the newly
discovered iron-based superconductor Sr2ScFePO3. A zero bias conductance peak
which disappears at the superconducting transition temperature, dominates all
of the spectra. Data taken in high magnetic fields show that this feature
survives until 7T at 2K and a flattening of the feature is observed in some
contacts. Here we inspect whether these observations can be interpreted within
a d-wave, or nodal order parameter framework which would be consistent with the
recent theoretical model where the height of the P in the Fe-P-Fe plane is key
to the symmetry of the superconductivity. However, in polycrystalline samples
care must be taken when examining Andreev spectra to eliminate or take into
account artefacts associated with the possible effects of Josephson junctions
and random alignment of grains.Comment: Published versio
Nonaqueous Fluoride/Chloride Anion-Promoted Delamination of Layered Zeolite Precursors: Synthesis and Characterization of UCB-2
The delamination of layered zeolite precursor PREFER is demonstrated under mild nonaqueous conditions using a mixture of cetyltrimethylammonium bromide, tetrabutylammonium fluoride, and tetrabutylammonium chloride in N,N-dimethylformamide (DMF) as solvent. The delamination proceeds through a swollen material intermediate which is characterized using powder X-ray diffraction (PXRD). Subsequent addition of concentrated HCl at room temperature leads to synthesis of UCB-2 via delamination of the swollen PREFER material and is characterized using PXRD, transmission electron microscopy (TEM), and argon gas physisorption, which shows lack of microporosity in UCB-2. ^(29)Si magic angle spinning (MAS) NMR spectroscopy indicates lack of amorphization during delamination, as indicated by the entire absence of Q^2 resonances, and ^(27)Al MAS NMR spectroscopy shows exclusively tetrahedral aluminum in the framework following delamination. The delamination process requires both chloride and fluoride anions and is sensitive to solvent, working well in DMF. Experiments aimed at synthesizing UCB-2 using aqueous conditions previously used for UCB-1 synthesis leads to partial swelling and lack of delamination upon acidification. A similar lack of delamination is observed upon attempting synthesis of UCB-1 under conditions used for UCB-2 synthesis. The delamination of PREFER is reversible between delaminated and swollen states in the following manner. Treatment of as-made UCB-2 with the same reagents as used here for the swelling of PREFER causes the delaminated UCB-2 material to revert back to swollen PREFER. This causes the delaminated UCB-2 material to revert back to swollen PREFER. Altogether, these results highlight delamination as the reverse of zeolite synthesis and demonstrate the crucial role of noncovalent self-assembly involving the zeolitic framework and cations/anions/structure-directing agent and solvent during the delamination process
Microscopic analysis of the chemical reaction between Fe(Te,Se) thin films and underlying CaF
To understand the chemical reaction at the interface of materials, we
performed a transmission electron microscopy (TEM) observation in four types of
Fe(Te,Se) superconducting thin films prepared on different types of substrates:
CaF2 substrate, CaF2 substrate with a CaF2 buffer layer, CaF2 substrate with a
FeSe buffer layer, and a LaAlO3 substrate with a CaF2 buffer layer. Based on
the energy-dispersive X-ray spectrometer (EDX) analysis, we found possible
interdiffusion between fluorine and selenium that has a strong influence on the
superconductivity in Fe(Te,Se) films. The chemical interdiffusion also plays a
significant role in the variation of the lattice parameters. The lattice
parameters of the Fe(Te,Se) thin films are primarily determined by the chemical
substitution of anions, and the lattice mismatch only plays a secondary role.Comment: 30 pages, 9 figur
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
<p>Abstract</p> <p>Background:</p> <p>The CpG island methylator phenotype (CIMP) with widespread promoter methylation is a distinct epigenetic phenotype in colorectal cancer, associated with microsatellite instability-high (MSI-high) and <it>BRAF </it>mutations. 18q loss of heterozygosity (LOH) commonly present in colorectal cancer with chromosomal instability (CIN) is associated with global hypomethylation in tumor cell. A recent study has shown an inverse correlation between CIN and CIMP (determined by MINTs, p16, p14 and <it>MLH1 </it>methylation) in colorectal cancer. However, no study has examined 18q LOH in relation to CIMP-high, CIMP-low (less extensive promoter methylation) and CIMP-0 (CIMP-negative), determined by quantitative DNA methylation analysis.</p> <p>Methods:</p> <p>Utilizing MethyLight technology (real-time PCR), we quantified DNA methylation in 8 CIMP-specific promoters {<it>CACNA1G</it>, <it>CDKN2A </it>(p16), <it>CRABP1, IGF2</it>, <it>MLH1, NEUROG1, RUNX3 </it>and <it>SOCS1</it>} in 758 non-MSI-high colorectal cancers obtained from two large prospective cohorts. Using four 18q microsatellite markers (D18S55, D18S56, D18S67 and D18S487) and stringent criteria for 18q LOH, we selected 374 tumors (236 LOH-positive tumors with β₯ 2 markers showing LOH; and 138 LOH-negative tumors with β₯ 3 informative markers and no LOH).</p> <p>Results:</p> <p>CIMP-0 (0/8 methylated promoters) was significantly more common in 18q LOH-positive tumors (59% = 139/236, p = 0.002) than 18q LOH-negative tumors (44% = 61/138), while CIMP-low/high (1/8β8/8 methylated promoters) was significantly more common (56%) in 18q LOH-negative tumors than 18q LOH-positive tumors (41%). These relations persisted after stratification by sex, location, or the status of MSI, p53 expression (by immunohistochemistry), or <it>KRAS/BRAF </it>mutation.</p> <p>Conclusion:</p> <p>18q LOH is correlated positively with CIMP-0 and inversely with CIMP-low and CIMP-high. Our findings provide supporting evidence for relationship between CIMP-0 and 18q LOH as well as a molecular difference between CIMP-0 and CIMP-low in colorectal cancer.</p
Micellization of Sliding Polymer Surfactants
Following up a recent paper on grafted sliding polymer layers (Macromolecules
2005, 38, 1434-1441), we investigated the influence of the sliding degree of
freedom on the self-assembly of sliding polymeric surfactants that can be
obtained by complexation of polymers with cyclodextrins. In contrast to the
micelles of quenched block copolymer surfactants, the free energy of micelles
of sliding surfactants can have two minima: the first corresponding to small
micelles with symmetric arm lengths, and the second corresponding to large
micelles with asymmetric arm lengths. The relative sizes and concentrations of
small and large micelles in the solution depend on the molecular parameters of
the system. The appearance of small micelles drastically reduces the kinetic
barrier signifying the fast formation of equilibrium micelles.Comment: Submitted to Macromolecule
TGFBR2 and BAX Mononucleotide Tract Mutations, Microsatellite Instability, and Prognosis in 1072 Colorectal Cancers
Mononucleotide tracts in the coding regions of the TGFBR2 and BAX genes are commonly mutated in microsatellite instability-high (MSI-high) colon cancers. The receptor TGFBR2 plays an important role in the TGFB1 (transforming growth factor-Ξ², TGF-Ξ²) signaling pathway, and BAX plays a key role in apoptosis. However, a role of TGFBR2 or BAX mononucleotide mutation in colorectal cancer as a prognostic biomarker remains uncertain.We utilized a database of 1072 rectal and colon cancers in two prospective cohort studies (the Nurses' Health Study and the Health Professionals Follow-up Study). Cox proportional hazards model was used to compute mortality hazard ratio (HR), adjusted for clinical, pathological and molecular features including the CpG island methylator phenotype (CIMP), LINE-1 methylation, and KRAS, BRAF and PIK3CA mutations. MSI-high was observed in 15% (162/1072) of all colorectal cancers. TGFBR2 and BAX mononucleotide mutations were detected in 74% (117/159) and 30% (48/158) of MSI-high tumors, respectively. In Kaplan-Meier analysis as well as univariate and multivariate Cox regression analyses, compared to microsatellite stable (MSS)/MSI-low cases, MSI-high cases were associated with superior colorectal cancer-specific survival [adjusted HR, 0.34; 95% confidence interval (CI), 0.20-0.57] regardless of TGFBR2 or BAX mutation status. Among MSI-high tumors, TGFBR2 mononucleotide mutation was associated with CIMP-high independent of other variables [multivariate odds ratio, 3.57; 95% CI, 1.66-7.66; pβ=β0.0011].TGFBR2 or BAX mononucleotide mutations are not associated with the patient survival outcome in MSI-high colorectal cancer. Our data do not support those mutations as prognostic biomarkers (beyond MSI) in colorectal carcinoma
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
- β¦